SulfadoxinePyrimethamineSulfanilamidesAntimalarialsDihydropteroate SynthaseDrug CombinationsDrug ResistanceChloroquineTetrahydrofolate DehydrogenaseDapsonePlasmodium falciparumSulfadiazineProguanilMalaria, FalciparumFolic Acid AntagonistsMefloquineMalariaCongoParasitic Sensitivity TestsSesquiterpenesDNA, ProtozoanArtemisininsAmodiaquineDrug Therapy, CombinationToxoplasmosis, CerebralPlasmodium vivaxGenes, ProtozoanSulfaleneParasitemiaAtovaquoneAntiprotozoal AgentsToxoplasmaKenyaTriazines4-Aminobenzoic AcidTanzaniaQuinolinesGangliosidoses, GM2Drug EvaluationPoint MutationToxoplasmosis, AnimalSulfamerazineNaphthoquinonesToxoplasmosisCoccidiostatsCameroonChorioretinitisDrug Resistance, MicrobialTreatment FailureMutationInhibitory Concentration 50TrimethoprimToxoplasmosis, CongenitalPregnancy Complications, ParasiticAllelesTrimetrexateQuinineGabonEncephalitisGenotypeToxoplasmosis, OcularPrimaquineSulfinpyrazoneProtozoan ProteinsTreatment OutcomeSomaliaRNA, ProtozoanThymidylate SynthasePneumonia, PneumocystisComorosMadagascarTrimethoprim-Sulfamethoxazole CombinationSenegalCentral African RepublicAnti-Infective AgentsAngolaPneumocystis InfectionsMali